We are live on ! Find out more
SCMP

Sucampo Pharmaceuticals, Inc.
SCMP

Delisted

SCMP was delisted on the 12th of February, 2018.

Back to rankings

167 hedge funds and large institutions have $287M invested in Sucampo Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 57 increasing their positions, 47 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 30

32% more call options, than puts

Call options by funds: $1.48M | Put options by funds: $1.12M

21% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 47

1% more funds holding

Funds holding: 165 → 167 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

16% less capital invested

Capital invested by funds: $340M → $287M (-$52.9M)

Holders
167
Holders Change
+2
Holders Change %
+1.21%
% of All Funds
4.16%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
40
Increased
57
Reduced
47
Closed
30
Calls
$1.48M
Puts
$1.12M
Net Calls
+$359K
Net Calls Change
+$1.1M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$41.4M
2
KAM
Krensavage Asset Management
New York
+$10.9M
3
Millennium Management
Millennium Management
New York
+$6.03M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$5.55M
5
GCP
GSA Capital Partners
United Kingdom
+$2.88M

Top Sellers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
-$6.78M
2
Invesco
Invesco
Georgia
-$5.41M
3
NI
Numeric Investors
Massachusetts
-$5.02M
4
TA
Teachers Advisors
New York
-$4.86M
5
Renaissance Technologies
Renaissance Technologies
New York
-$4.04M
Name Holding Trade Value Shares
Change 		Change in
Stake
DIA
26
Dana Investment Advisors
Wisconsin
$1.76M +$249K +21,434 +15%
MC
27
Menta Capital
California
$1.54M -$293K -25,243 -15%
SCP
28
Seizert Capital Partners
Michigan
$1.45M +$1.53M +131,703 New
Ameriprise
29
Ameriprise
Minnesota
$1.43M +$1.51M +130,100 New
Acadian Asset Management
30
Acadian Asset Management
Massachusetts
$1.43M -$2.35M -202,562 -61%
MCM
31
McKinley Capital Management
Alaska
$1.42M +$836 +72 +0.1%
BGIM
32
Brandywine Global Investment Management
Pennsylvania
$1.33M +$653K +56,296 +88%
QI
33
QS Investors
New York
$1.28M – – –
TCIM
34
TIAA CREF Investment Management
New York
$1.24M -$997K -85,924 -43%
AQR Capital Management
35
AQR Capital Management
Connecticut
$1.21M +$719K +61,971 +129%
ACM
36
Ativo Capital Management
Illinois
$1.2M – – –
ARTA
37
A.R.T. Advisors
New York
$1.19M +$1.06M +90,900 +528%
Morgan Stanley
38
Morgan Stanley
New York
$1.16M -$3.24M -278,818 -73%
GC
39
Globeflex Capital
California
$1.14M +$510K +43,900 +73%
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
$1.08M +$547K +47,089 +92%
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$1.05M -$215K -18,542 -16%
CCMG
42
Clark Capital Management Group
Pennsylvania
$991K +$360K +31,057 +53%
Bank of America
43
Bank of America
North Carolina
$989K +$194K +16,730 +23%
NI
44
Numeric Investors
Massachusetts
$983K -$5.02M -432,700 -83%
TI
45
Trexquant Investment
Connecticut
$945K +$576K +49,622 +137%
HCM
46
Highbridge Capital Management
New York
$942K +$994K +85,629 New
SM
47
Sabby Management
Florida
$935K +$116K +10,000 +13%
GC
48
Guggenheim Capital
Illinois
$911K +$962K +82,879 New
MCC
49
Malaga Cove Capital
California
$897K +$515K +44,384 +111%
CCM
50
Cadence Capital Management
Massachusetts
$885K -$423K -36,441 -31%
1
2
3 4 5

SCMP Hedge Fund Activity: Q1 2017 in Review

167 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Sucampo Pharmaceuticals, Inc. (SCMP) for Q1 2017, worth a combined $287M — down 16% from $340M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new SCMP positions and 30 closed out — a net gain of 10 holders — while 57 added to existing stakes and 47 trimmed.

The largest buyer was BlackRock, adding an estimated $41.4M. The largest seller was UBS O'Connor, exiting entirely with an estimated $6.78M sold.

  • 167 institutional investors held Sucampo Pharmaceuticals, Inc. (SCMP) as of Q1 2017, up from 165 in Q4 2016.
  • Funds reported $287M of Sucampo Pharmaceuticals, Inc. stock for Q1 2017, down 16% quarter-over-quarter.
  • 40 funds opened new Sucampo Pharmaceuticals, Inc. positions in Q1 2017 and 30 closed out, a net change of +10 holders.
  • The largest Sucampo Pharmaceuticals, Inc. buyer in Q1 2017 was BlackRock, an estimated $41.4M added.
  • The largest Sucampo Pharmaceuticals, Inc. seller in Q1 2017 was UBS O'Connor, an estimated $6.78M sold.

Based on aggregated 13F filings for Q1 2017.